Allogeneic islet transplantation

Simona Marzorati, Antonello Pileggi, Camillo Ricordi

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Significant progress has been made in the field of β-cell replacement therapies by islet transplantation in patients with unstable Type 1 diabetes mellitus (T1DM). Recent clinical trials have shown that islet transplantation can reproducibly lead to insulin independence when adequate islet numbers are implanted. Benefits include improvement of glycemic control, prevention of severe hypoglycemia and amelioration of quality of life. Numerous challenges still limit this therapeutic option from becoming the treatment of choice for T1DM. The limitations are primarily associated with the low islet yield of human pancreas isolations and the need for chronic immunosuppressive therapies. Herein the authors present an overview of the historical progress of islet transplantation and outline the recent advances of the field. Cellular therapies offer the potential for a cure for patients with T1DM. The progress in β-cell replacement treatment by islet transplantation as well as those of emerging immune interventions for the restoration of self tolerance justify great optimism for years to come.

Original languageEnglish
Pages (from-to)1627-1645
Number of pages19
JournalExpert Opinion on Biological Therapy
Volume7
Issue number11
DOIs
StatePublished - Nov 1 2007

Fingerprint

Islets of Langerhans Transplantation
Homologous Transplantation
Medical problems
Type 1 Diabetes Mellitus
Immunosuppressive Agents
Restoration
Self Tolerance
Therapeutics
Insulin
Cell- and Tissue-Based Therapy
Hypoglycemia
Pancreas
Quality of Life
Clinical Trials

Keywords

  • β-cells
  • Clinical trials
  • Insulin independence
  • Islet transplantation
  • Type 1 diabetes

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics
  • Immunology

Cite this

Allogeneic islet transplantation. / Marzorati, Simona; Pileggi, Antonello; Ricordi, Camillo.

In: Expert Opinion on Biological Therapy, Vol. 7, No. 11, 01.11.2007, p. 1627-1645.

Research output: Contribution to journalArticle

Marzorati, Simona ; Pileggi, Antonello ; Ricordi, Camillo. / Allogeneic islet transplantation. In: Expert Opinion on Biological Therapy. 2007 ; Vol. 7, No. 11. pp. 1627-1645.
@article{0142ce83ead94cb5993294002984786e,
title = "Allogeneic islet transplantation",
abstract = "Significant progress has been made in the field of β-cell replacement therapies by islet transplantation in patients with unstable Type 1 diabetes mellitus (T1DM). Recent clinical trials have shown that islet transplantation can reproducibly lead to insulin independence when adequate islet numbers are implanted. Benefits include improvement of glycemic control, prevention of severe hypoglycemia and amelioration of quality of life. Numerous challenges still limit this therapeutic option from becoming the treatment of choice for T1DM. The limitations are primarily associated with the low islet yield of human pancreas isolations and the need for chronic immunosuppressive therapies. Herein the authors present an overview of the historical progress of islet transplantation and outline the recent advances of the field. Cellular therapies offer the potential for a cure for patients with T1DM. The progress in β-cell replacement treatment by islet transplantation as well as those of emerging immune interventions for the restoration of self tolerance justify great optimism for years to come.",
keywords = "β-cells, Clinical trials, Insulin independence, Islet transplantation, Type 1 diabetes",
author = "Simona Marzorati and Antonello Pileggi and Camillo Ricordi",
year = "2007",
month = "11",
day = "1",
doi = "10.1517/14712598.7.11.1627",
language = "English",
volume = "7",
pages = "1627--1645",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Informa Healthcare",
number = "11",

}

TY - JOUR

T1 - Allogeneic islet transplantation

AU - Marzorati, Simona

AU - Pileggi, Antonello

AU - Ricordi, Camillo

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Significant progress has been made in the field of β-cell replacement therapies by islet transplantation in patients with unstable Type 1 diabetes mellitus (T1DM). Recent clinical trials have shown that islet transplantation can reproducibly lead to insulin independence when adequate islet numbers are implanted. Benefits include improvement of glycemic control, prevention of severe hypoglycemia and amelioration of quality of life. Numerous challenges still limit this therapeutic option from becoming the treatment of choice for T1DM. The limitations are primarily associated with the low islet yield of human pancreas isolations and the need for chronic immunosuppressive therapies. Herein the authors present an overview of the historical progress of islet transplantation and outline the recent advances of the field. Cellular therapies offer the potential for a cure for patients with T1DM. The progress in β-cell replacement treatment by islet transplantation as well as those of emerging immune interventions for the restoration of self tolerance justify great optimism for years to come.

AB - Significant progress has been made in the field of β-cell replacement therapies by islet transplantation in patients with unstable Type 1 diabetes mellitus (T1DM). Recent clinical trials have shown that islet transplantation can reproducibly lead to insulin independence when adequate islet numbers are implanted. Benefits include improvement of glycemic control, prevention of severe hypoglycemia and amelioration of quality of life. Numerous challenges still limit this therapeutic option from becoming the treatment of choice for T1DM. The limitations are primarily associated with the low islet yield of human pancreas isolations and the need for chronic immunosuppressive therapies. Herein the authors present an overview of the historical progress of islet transplantation and outline the recent advances of the field. Cellular therapies offer the potential for a cure for patients with T1DM. The progress in β-cell replacement treatment by islet transplantation as well as those of emerging immune interventions for the restoration of self tolerance justify great optimism for years to come.

KW - β-cells

KW - Clinical trials

KW - Insulin independence

KW - Islet transplantation

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=36048963197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36048963197&partnerID=8YFLogxK

U2 - 10.1517/14712598.7.11.1627

DO - 10.1517/14712598.7.11.1627

M3 - Article

VL - 7

SP - 1627

EP - 1645

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 11

ER -